Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement [Yahoo! Finance]
Callan JMB Inc. (CJMB)
Company Research
Source: Yahoo! Finance
SPRING BRANCH, Texas, March 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics and operational infrastructure company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its role as an independent infrastructure and oversight partner in a collaboration led by DifGen Pharmaceuticals and Aveva Drug Delivery Systems, alongside Biostax Corp (“Biostax”), doing business as Attune Biotech (“Attune”), and SGP Holdings. The collaboration supports U.S.-based technology transfer, formulation development, and manufacturing scale-up for the JKB-122 (Lodonal ™ ) immune restoration platform. Callan JMB's role focuses on independent validation across manufacturing, quality systems, and supply chain operations—helping ensure consistency, compliance, and readiness as the program advances toward Phase 2b/3 clinical development
Show less
Read more
Impact Snapshot
Event Time:
CJMB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CJMB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CJMB alerts
High impacting Callan JMB Inc. news events
Weekly update
A roundup of the hottest topics
CJMB
News
- Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 AdvancementGlobeNewswire
- Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVIDGlobeNewswire
- Callan JMB Inc. (CJMB) Presents at IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026 [Yahoo! Finance]Yahoo! Finance
- Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026GlobeNewswire
CJMB
Sec Filings
- 3/26/26 - Form 4
- 3/12/26 - Form 8-K
- 3/10/26 - Form 4
- CJMB's page on the SEC website